Russell Investments Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Russell Investments Group’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,647	Closed	-$1.63M	–	3584
2023 Q1	$1.63M	Buy	67,647 +314	+0.5%	+$3.94K	﹤0.01%	1698
2022 Q4	$712K	Hold	67,333	–	–	﹤0.01%	2140
2022 Q3	$302K	Hold	67,333	–	–	﹤0.01%	2427
2022 Q2	$269K	Buy	+67,333	New	+$319K	﹤0.01%	2476
2020 Q3	–	Sell	-78,756	Closed	-$1.11M	–	3282
2020 Q2	$1.11M	Buy	+78,756	New	+$994K	﹤0.01%	1996

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Russell Investments Group's PRVB Position: Q2 2023 in Review

Russell Investments Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 67,647 shares — an estimated $1.63M sold.

Russell Investments Group first reported a position in PRVB in Q2 2020 and held it in 5 quarters. The position peaked at $1.63M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Russell Investments Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Russell Investments Group sold 67,647 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.63M.
Russell Investments Group first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Russell Investments Group's Provention Bio, Inc. Common Stock position peaked at $1.63M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Russell Investments Group's 13F filing for Q2 2023, filed 10 Aug 2023.